EMJ Neurology 12 [Supplement 2] . 2024

In this issue

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) differential diagnosis continues to be a challenge in neurology. This article details the recent MOGAD Masterclass in which 12 renewed experts from around the world discussed the diagnosis and management of the disease. This meeting was initiated funded and supported by UCB Biopharma SRL.